All News about Alvotech - Ordinary Shares
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech to Present at the Jefferies 2023 London Healthcare Conference
November 07, 2023
From Alvotech
Via GlobeNewswire
![](https://g.foolcdn.com/editorial/images/738205/biotech.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
October 20, 2023
Via Benzinga
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
From Alvotech
Via GlobeNewswire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Announces Approval in Japan of AVT04 (ustekinumab), a Biosimilar to Stelara®
September 25, 2023
From Alvotech
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023
September 21, 2023
Via Benzinga
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Announces Changes to the Leadership Team
September 05, 2023
From Alvotech
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
From Alvotech
Via GlobeNewswire
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.